JOHN STANILAND: Open Payments
NPI 1447264908 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$144 in 8 payments from 7 companies in 2025. Trend: 2023 $760 · 2024 $384 · 2025 $144
Food & beverage: $144
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $37 |
| Lilly USA, LLC | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $14 |
Products named: MOUNJARO, Wegovy, NP Thyroid 60, Korlym, Veozah, GVOKE HYPOPEN, Rybelsus, XYOSTED.
Industry payments across TX — which companies pay providers there.
